Chronic Psychiatric Disease Management Practice Test

A 48-year-old combat veteran has been treated for post-traumatic stress disorder (PTSD) for the past 18 months. He completed a full course of Cognitive Processing Therapy (CPT) and has been maintained on sertraline 150 mg daily. For the past year, he has had minimal PTSD symptoms, is working full-time, and has re-engaged with his family. He asks how much longer he needs to take the sertraline.

A 28-year-old man with a 7-year history of schizophrenia, paranoid type, is brought to the clinic by his case manager due to concerns about medication nonadherence. The patient has been hospitalized twice in the past year for psychotic relapses after discontinuing his oral risperidone. He agrees to transition to a long-acting injectable (LAI) formulation. The physician decides to start risperidone microspheres for intramuscular injection, which is administered every 2 weeks.